Connection

Gary Gilkeson to Animals

This is a "connection" page, showing publications Gary Gilkeson has written about Animals.
Connection Strength

1.784
  1. Safety and Efficacy of Mesenchymal Stromal Cells and Other Cellular Therapeutics in Rheumatic Diseases in 2022: A Review of What We Know So Far. Arthritis Rheumatol. 2022 05; 74(5):752-765.
    View in: PubMed
    Score: 0.060
  2. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice. PLoS One. 2020; 15(3):e0230499.
    View in: PubMed
    Score: 0.053
  3. Novel mechanism for estrogen receptor alpha modulation of murine lupus. J Autoimmun. 2019 02; 97:59-69.
    View in: PubMed
    Score: 0.048
  4. Estrogen Receptor a Deficiency Modulates TLR Ligand-Mediated PDC-TREM Expression in Plasmacytoid Dendritic Cells in Lupus-Prone Mice. J Immunol. 2015 Dec 15; 195(12):5561-71.
    View in: PubMed
    Score: 0.039
  5. Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. J Neuroinflammation. 2014 Dec 16; 11:171.
    View in: PubMed
    Score: 0.037
  6. Estrogen receptor alpha modulates mesangial cell responses to toll-like receptor ligands. Am J Med Sci. 2014 Dec; 348(6):492-500.
    View in: PubMed
    Score: 0.036
  7. Differential efficacy of human mesenchymal stem cells based on source of origin. J Immunol. 2014 Nov 01; 193(9):4381-90.
    View in: PubMed
    Score: 0.036
  8. NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis. Lupus. 2013 Nov; 22(13):1361-70.
    View in: PubMed
    Score: 0.034
  9. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. PLoS One. 2013; 8(5):e64650.
    View in: PubMed
    Score: 0.033
  10. Hematopoetic and mesenchymal stem cell transplantation in the treatment of refractory systemic lupus erythematosus--where are we now? Clin Immunol. 2013 Sep; 148(3):328-34.
    View in: PubMed
    Score: 0.032
  11. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. Clin Immunol. 2012 Nov; 145(2):142-52.
    View in: PubMed
    Score: 0.031
  12. Impact of sphingosine kinase 2 deficiency on the development of TNF-alpha-induced inflammatory arthritis. Rheumatol Int. 2013 Oct; 33(10):2677-81.
    View in: PubMed
    Score: 0.031
  13. Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus. Clin Immunol. 2012 Jul; 144(1):1-12.
    View in: PubMed
    Score: 0.030
  14. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther. 2011; 13(6):250.
    View in: PubMed
    Score: 0.030
  15. Impact of sphingosine kinase on inflammatory pathways in fibroblast-like synoviocytes. Inflamm Allergy Drug Targets. 2011 Dec; 10(6):464-71.
    View in: PubMed
    Score: 0.030
  16. Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol. 2011 Feb; 40(1):66-73.
    View in: PubMed
    Score: 0.028
  17. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Am J Med Sci. 2011 Feb; 341(2):101-5.
    View in: PubMed
    Score: 0.028
  18. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis. J Immunol. 2010 Aug 15; 185(4):2570-9.
    View in: PubMed
    Score: 0.027
  19. Assessment of trichloroethylene (TCE) exposure in murine strains genetically-prone and non-prone to develop autoimmune disease. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2009 Apr; 44(5):443-53.
    View in: PubMed
    Score: 0.025
  20. Lifetime exposure to trichloroethylene (TCE) does not accelerate autoimmune disease in MRL +/+ mice. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2008 Oct; 43(12):1402-9.
    View in: PubMed
    Score: 0.024
  21. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin Immunol. 2008 Aug; 128(2):259-68.
    View in: PubMed
    Score: 0.023
  22. Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage. Invest Ophthalmol Vis Sci. 2007 Nov; 48(11):5282-9.
    View in: PubMed
    Score: 0.022
  23. Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes. Mol Immunol. 2008 Jan; 45(1):1-12.
    View in: PubMed
    Score: 0.022
  24. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus. J Immunol. 2006 Nov 15; 177(10):7423-34.
    View in: PubMed
    Score: 0.021
  25. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin Immunol. 2006 Dec; 121(3):243-50.
    View in: PubMed
    Score: 0.020
  26. ETS transcription factors and regulation of immunity. Arch Immunol Ther Exp (Warsz). 2006 May-Jun; 54(3):149-63.
    View in: PubMed
    Score: 0.020
  27. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice. Eur J Immunol. 2006 May; 36(5):1296-308.
    View in: PubMed
    Score: 0.020
  28. Regulation of Fli1 gene expression and lupus. Autoimmun Rev. 2006 Jul; 5(6):377-82.
    View in: PubMed
    Score: 0.020
  29. Inflammatory modulation of PPAR gamma expression and activity. Clin Immunol. 2006 Feb-Mar; 118(2-3):276-83.
    View in: PubMed
    Score: 0.019
  30. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol. 2004 Nov 15; 173(10):6481-9.
    View in: PubMed
    Score: 0.018
  31. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J Immunol. 2004 Sep 15; 173(6):4171-8.
    View in: PubMed
    Score: 0.018
  32. Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. J Pharmacol Exp Ther. 2005 Jan; 312(1):69-76.
    View in: PubMed
    Score: 0.018
  33. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol. 2004 Mar 15; 172(6):3913-21.
    View in: PubMed
    Score: 0.017
  34. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int. 2004 Jan; 65(1):129-38.
    View in: PubMed
    Score: 0.017
  35. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. J Investig Med. 2004 Jan; 52(1):62-71.
    View in: PubMed
    Score: 0.017
  36. Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice. Clin Immunol. 2003 Jun; 107(3):186-97.
    View in: PubMed
    Score: 0.016
  37. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest. 2003 Feb; 111(4):539-52.
    View in: PubMed
    Score: 0.016
  38. Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus. Ann Rheum Dis. 2022 Dec; 81(12):1712-1721.
    View in: PubMed
    Score: 0.016
  39. Conditional knockout of oestrogen receptor alpha in CD11c+ cells impacts female survival and inflammatory cytokine profile in murine lupus. Immunology. 2022 11; 167(3):354-367.
    View in: PubMed
    Score: 0.015
  40. Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus. J Autoimmun. 2022 07; 131:102860.
    View in: PubMed
    Score: 0.015
  41. Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases. Arthritis Rheum. 2002 Mar; 46(3):598-605.
    View in: PubMed
    Score: 0.015
  42. Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice. Immunol Res. 2002; 25(2):143-53.
    View in: PubMed
    Score: 0.015
  43. Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages. Ann Rheum Dis. 2022 02; 81(2):255-267.
    View in: PubMed
    Score: 0.015
  44. Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB ? NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells. Arthritis Rheumatol. 2021 08; 73(8):1478-1488.
    View in: PubMed
    Score: 0.014
  45. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J Immunol. 2001 May 15; 166(10):6444-51.
    View in: PubMed
    Score: 0.014
  46. Prostaglandin J(2) inhibition of mesangial cell iNOS expression. Clin Immunol. 2001 Mar; 98(3):337-45.
    View in: PubMed
    Score: 0.014
  47. Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target. J Immunol. 2021 01 01; 206(1):59-66.
    View in: PubMed
    Score: 0.014
  48. Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice. J Autoimmun. 2020 03; 108:102420.
    View in: PubMed
    Score: 0.013
  49. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. J Immunol. 2000 Feb 01; 164(3):1498-504.
    View in: PubMed
    Score: 0.013
  50. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol. 2000 Jan 15; 164(2):786-94.
    View in: PubMed
    Score: 0.013
  51. Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 Fas(lpr) mice. Clin Immunol. 2000 Jan; 94(1):24-32.
    View in: PubMed
    Score: 0.013
  52. Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice. J Immunol. 1998 Oct 15; 161(8):3890-5.
    View in: PubMed
    Score: 0.012
  53. Intestinal macrophages in mucosal immunity and their role in systemic lupus erythematosus disease. Lupus. 2018 Oct; 27(12):1898-1902.
    View in: PubMed
    Score: 0.012
  54. Soluble CD16 in the treatment of murine lupus nephritis. Clin Immunol Immunopathol. 1998 Jul; 88(1):91-5.
    View in: PubMed
    Score: 0.012
  55. B lymphocytes confer immune tolerance via cell surface GARP-TGF-? complex. JCI Insight. 2018 04 05; 3(7).
    View in: PubMed
    Score: 0.011
  56. Influence of VH CDR3 arginine and light chain pairing on DNA reactivity of a bacterial DNA-induced anti-DNA antibody from a BALB/c mouse. J Immunol. 1997 Dec 15; 159(12):6083-90.
    View in: PubMed
    Score: 0.011
  57. Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function. Stem Cell Res Ther. 2017 08 30; 8(1):192.
    View in: PubMed
    Score: 0.011
  58. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med. 1997 Aug 04; 186(3):365-73.
    View in: PubMed
    Score: 0.011
  59. Molecular properties of anti-DNA induced in preautoimmune NZB/W mice by immunization with bacterial DNA. J Immunol. 1997 May 01; 158(9):4500-6.
    View in: PubMed
    Score: 0.011
  60. Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol. 1997 Apr; 83(1):86-92.
    View in: PubMed
    Score: 0.011
  61. Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease. Clin Immunol. 2017 02; 175:109-114.
    View in: PubMed
    Score: 0.011
  62. Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases. Clin Immunol. 2016 Dec; 173:81-86.
    View in: PubMed
    Score: 0.010
  63. Differences in V kappa gene utilization and VH CDR3 sequence among anti-DNA from C3H-lpr mice and lupus mice with nephritis. Eur J Immunol. 1996 Sep; 26(9):2225-33.
    View in: PubMed
    Score: 0.010
  64. Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factor. Eur J Immunol. 2016 10; 46(10):2322-2332.
    View in: PubMed
    Score: 0.010
  65. Murine glomerulotropic monoclonal antibodies are highly oligoclonal and exhibit distinctive molecular features. J Immunol. 1996 Aug 01; 157(3):1297-305.
    View in: PubMed
    Score: 0.010
  66. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med. 1996 Apr 01; 183(4):1389-97.
    View in: PubMed
    Score: 0.010
  67. The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol. 1995 Jul; 76(1 Pt 1):59-67.
    View in: PubMed
    Score: 0.009
  68. Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. Am J Hum Genet. 2015 May 07; 96(5):731-9.
    View in: PubMed
    Score: 0.009
  69. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest. 1995 Mar; 95(3):1398-402.
    View in: PubMed
    Score: 0.009
  70. A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression. Arthritis Rheumatol. 2014 Dec; 66(12):3436-44.
    View in: PubMed
    Score: 0.009
  71. Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases. Semin Thromb Hemost. 2014 Sep; 40(6):675-81.
    View in: PubMed
    Score: 0.009
  72. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med. 1994 Feb 01; 179(2):651-60.
    View in: PubMed
    Score: 0.009
  73. Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA. Clin Immunol Immunopathol. 1993 Sep; 68(3):283-92.
    View in: PubMed
    Score: 0.008
  74. ABIN1 dysfunction as a genetic basis for lupus nephritis. J Am Soc Nephrol. 2013 Nov; 24(11):1743-54.
    View in: PubMed
    Score: 0.008
  75. Molecular characterization of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Differences from spontaneous anti-DNA in the content and location of VH CDR3 arginines. J Immunol. 1993 Aug 01; 151(3):1353-64.
    View in: PubMed
    Score: 0.008
  76. The transcription factor Fli-1 regulates monocyte, macrophage and dendritic cell development in mice. Immunology. 2013 Jul; 139(3):318-27.
    View in: PubMed
    Score: 0.008
  77. The fine specificity of monoclonal anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. J Autoimmun. 1993 Feb; 6(1):11-26.
    View in: PubMed
    Score: 0.008
  78. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant. 2013; 22(12):2279-90.
    View in: PubMed
    Score: 0.008
  79. Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney. Clin Immunol. 2012 Dec; 145(3):201-8.
    View in: PubMed
    Score: 0.008
  80. A role for estrogen receptor-a and estrogen receptor-? in collagen biosynthesis in mouse skin. J Invest Dermatol. 2013 Jan; 133(1):120-7.
    View in: PubMed
    Score: 0.008
  81. Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice. Clin Immunol Immunopathol. 1992 Aug; 64(2):166-72.
    View in: PubMed
    Score: 0.008
  82. The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition. Mol Immunol. 2011 Oct; 49(1-2):317-23.
    View in: PubMed
    Score: 0.007
  83. Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation. Mol Immunol. 2011 Oct; 49(1-2):64-74.
    View in: PubMed
    Score: 0.007
  84. Genetic control of inflammatory arthritis and glomerulonephritis in congenic lpr mice and their F1 hybrids. J Autoimmun. 1991 Aug; 4(4):595-606.
    View in: PubMed
    Score: 0.007
  85. Specificity of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Clin Immunol Immunopathol. 1991 May; 59(2):288-300.
    View in: PubMed
    Score: 0.007
  86. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice. Arthritis Rheum. 2011 Apr; 63(4):1076-85.
    View in: PubMed
    Score: 0.007
  87. Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Mol Cell Biol. 2010 Nov; 30(21):5194-206.
    View in: PubMed
    Score: 0.007
  88. Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice. Clin Exp Immunol. 2010 Nov; 162(2):362-71.
    View in: PubMed
    Score: 0.007
  89. Cellular requirements for anti-DNA production induced in mice by immunization with bacterial DNA. Eur J Immunol. 1990 Aug; 20(8):1789-94.
    View in: PubMed
    Score: 0.007
  90. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus. 2010 Nov; 19(13):1502-14.
    View in: PubMed
    Score: 0.007
  91. A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 1990 Feb; 33(2):153-9.
    View in: PubMed
    Score: 0.007
  92. A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. Adv Exp Med Biol. 2010; 703:137-49.
    View in: PubMed
    Score: 0.006
  93. Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice. Clin Exp Immunol. 2010 May; 160(2):275-82.
    View in: PubMed
    Score: 0.006
  94. Genetic control of inflammatory arthritis in congenic lpr mice. Clin Immunol Immunopathol. 1989 Dec; 53(3):460-74.
    View in: PubMed
    Score: 0.006
  95. The antibody response of normal mice to immunization with single-stranded DNA of various species origin. Clin Immunol Immunopathol. 1989 Jun; 51(3):362-71.
    View in: PubMed
    Score: 0.006
  96. Comment on "Reassessment of the role of mut S homolog 5 in Ig class switch recombination shows lack of involvement in cis- and trans-switching". J Immunol. 2009 Apr 15; 182(8):4495-6; author reply 496-7.
    View in: PubMed
    Score: 0.006
  97. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2009 Apr 14; 106(15):6256-61.
    View in: PubMed
    Score: 0.006
  98. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009 Jul; 50(7):3056-64.
    View in: PubMed
    Score: 0.006
  99. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol. 1989 Mar 01; 142(5):1482-6.
    View in: PubMed
    Score: 0.006
  100. N,N,-diethyl-m-toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice. Toxicol Sci. 2009 Mar; 108(1):110-23.
    View in: PubMed
    Score: 0.006
  101. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene. J Investig Med. 2008 Oct; 56(7):911-9.
    View in: PubMed
    Score: 0.006
  102. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J. 2009 Jan; 23(1):143-52.
    View in: PubMed
    Score: 0.006
  103. A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis. Clin Immunol. 2008 Oct; 129(1):19-30.
    View in: PubMed
    Score: 0.006
  104. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice. J Immunol. 2008 Aug 01; 181(3):1644-54.
    View in: PubMed
    Score: 0.006
  105. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. J Autoimmun. 2008 Sep; 31(2):123-30.
    View in: PubMed
    Score: 0.006
  106. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci. 2008 Jul; 104(1):144-54.
    View in: PubMed
    Score: 0.006
  107. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. J Immunol. 2008 Jan 15; 180(2):1231-8.
    View in: PubMed
    Score: 0.006
  108. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur J Immunol. 2007 Jun; 37(6):1691-701.
    View in: PubMed
    Score: 0.005
  109. The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy. Am J Physiol Renal Physiol. 2007 Aug; 293(2):F555-64.
    View in: PubMed
    Score: 0.005
  110. Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci U S A. 2007 Apr 24; 104(17):7193-8.
    View in: PubMed
    Score: 0.005
  111. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. Am J Pathol. 2007 Apr; 170(4):1258-66.
    View in: PubMed
    Score: 0.005
  112. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum. 2006 Jul; 54(7):2198-210.
    View in: PubMed
    Score: 0.005
  113. Genomic view of systemic autoimmunity in MRLlpr mice. Genes Immun. 2006 Mar; 7(2):156-68.
    View in: PubMed
    Score: 0.005
  114. Developmental immunotoxicity of trichloroethylene (TCE): studies in B6C3F1 mice. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006; 41(3):249-71.
    View in: PubMed
    Score: 0.005
  115. Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. J Immunol. 2005 Apr 15; 174(8):5065-73.
    View in: PubMed
    Score: 0.005
  116. A novel PPAR response element in the murine iNOS promoter. Mol Immunol. 2005 Jul; 42(11):1303-10.
    View in: PubMed
    Score: 0.005
  117. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. Mol Immunol. 2005 Jan; 42(1):87-97.
    View in: PubMed
    Score: 0.005
  118. Immunological and hematological effects observed in B6C3F1 mice exposed to JP-8 jet fuel for 14 days. J Toxicol Environ Health A. 2004 Jul 23; 67(14):1109-29.
    View in: PubMed
    Score: 0.004
  119. Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice. Immunopharmacol Immunotoxicol. 2004 Feb; 26(1):1-15.
    View in: PubMed
    Score: 0.004
  120. Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus. Genes Immun. 2003 Dec; 4(8):575-85.
    View in: PubMed
    Score: 0.004
  121. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. Shock. 2003 Jul; 20(1):56-62.
    View in: PubMed
    Score: 0.004
  122. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol. 2003 Feb 01; 170(3):1517-23.
    View in: PubMed
    Score: 0.004
  123. Evaluation of immunotoxicity induced by single or concurrent exposure to N,N-diethyl-m-toluamide (DEET), pyridostigmine bromide (PYR), and JP-8 jet fuel. Toxicol Ind Health. 2001 Jun; 17(5-10):192-209.
    View in: PubMed
    Score: 0.004
  124. Hemorrhage and thrombus formation in early experimental osteonecrosis. Clin Orthop Relat Res. 2001 May; (386):11-8.
    View in: PubMed
    Score: 0.004
  125. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. J Leukoc Biol. 2001 Apr; 69(4):631-8.
    View in: PubMed
    Score: 0.004
  126. Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice. Mol Med. 2000 Sep; 6(9):779-92.
    View in: PubMed
    Score: 0.003
  127. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A. 2000 Jun 06; 97(12):6670-5.
    View in: PubMed
    Score: 0.003
  128. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest. 1999 Jun; 103(12):1685-95.
    View in: PubMed
    Score: 0.003
  129. Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice. Free Radic Biol Med. 1998 Jan 01; 24(1):191-6.
    View in: PubMed
    Score: 0.003
  130. Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction. J Clin Invest. 1997 Sep 01; 100(5):986-95.
    View in: PubMed
    Score: 0.003
  131. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity. 1996 May; 4(5):445-54.
    View in: PubMed
    Score: 0.003
  132. Effect of sex on the induction of anti-DNA antibodies in normal mice immunized with bacterial DNA. Lupus. 1993 Aug; 2(4):251-5.
    View in: PubMed
    Score: 0.002
  133. Detection of glomerular-binding immune elements in murine lupus using a tissue-based ELISA. Clin Exp Immunol. 1993 Mar; 91(3):449-55.
    View in: PubMed
    Score: 0.002
  134. The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. Cell Immunol. 1993 Mar; 147(1):148-57.
    View in: PubMed
    Score: 0.002
  135. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992 Dec 01; 176(6):1645-56.
    View in: PubMed
    Score: 0.002
  136. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol. 1991 Sep 15; 147(6):1759-64.
    View in: PubMed
    Score: 0.002
  137. Selective recognition of DNA antigenic determinants by murine monoclonal anti-DNA antibodies. Clin Exp Immunol. 1990 Oct; 82(1):33-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.